RECENT NEWS

For the first time, genomic data for over 37,000 children and parents collected over multiple decades from across the UK are now available to researchers worldwide.

Precision cancer diagnostics firm Epredia has announced U.S. Food and Drug Administration (FDA) 510(K) clearance for its E1000 Dx digital pathology solution.

The NIHR HealthTech Research Centre in In Vitro Diagnostics (HRC IVD) recently launched, bringing together industry, academia, and the healthcare sector to discuss the Centre’s ambitions and priorities.

The government has announced the appointment of Lawrence Tallon as the new Chief Executive Officer at the Medicines and Healthcare products Regulatory Agency (MHRA).

Registration is now open for the British Society for Microbial Technology (BSMT) Microbiology Conference, taking place at the RAF Museum in Hendon, North London, on 15 May.

A new AI-based tool for identifying colorectal cancer from tissue sample analysis has been developed at the University of Jyväskylä, Finland. The new artificial neural network model has surpassed all its predecessors in classification performance.

Enterprise imaging and informatics firm Fujifilm has announced a new partnership with Tiger Health Technology, a leading provider of hybrid cloud solutions, to optimise data lifecycle management and address key storage-related challenges in digital pathology.

Registrations and abstract submissions for the 2025 Annual SHOT Symposium are now open. Join the Serious Hazards of Transfusion (SHOT) scheme for an engaging and inspiring event, featuring insightful discussions, presentations from expert speakers, key highlights from the latest Annual SHOT Report, and valuable networking opportunities.

A new home test to diagnose type 1 diabetes (T1D) is being investigated in a major UK study led by researchers at the National Institute for Health and Care Research (NIHR) Oxford Biomedical Research Centre.

The latest UK Health Security Agency (UKHSA) data shows norovirus cases continue to rise across the country, with laboratory reports at the highest levels since reporting data this way began in 2014. People who have already had the virus this winter could be at risk again, UKHSA is warning, as new data shows a shift in circulating strains.

In response to the National Audit Office (NAO) report, the British In Vitro Diagnostics Association (BIVDA) calls urgently for improved diagnostic infrastructure and deployment to address antimicrobial resistance (AMR) effectively.

A National Audit Office report into the Government’s efforts to contain antimicrobial resistance (AMR) has found that only one of the five targets was met or is on track. Resistant infections are still rising as it proves hard to shift the behaviours of millions of citizens and thousands of institutions.

UK MedTech firm Presymptom Health has secured £200,000 in additional grant funding to speed-up its AI-driven infection detection technology, cutting test times to just 40-60 minutes. Presymptom Health will also use the funding to make its rapid tests compatible with a variety of widely available PCR machines, streamlining diagnostics is secondary care.

Thermo Fisher Scientific has announced that the company has entered into a definitive agreement with Solventum to acquire its Purification & Filtration business for approximately $4.1 billion in cash.

Aptitude Medical Systems has received Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for its next-gen molecular Metrix COVID-19/Flu multiplex test.

Amanda Pritchard has formally notified the NHS England Board of her decision to stand down as Chief Executive at the end of this financial year.

Spanish hospital group Vall d’Hebron has entered into a new strategic research partnership with bioMérieux. This collaboration aims to advance research and development in the areas of infectious diseases, data surveillance, and laboratory automation.

Alpha Laboratories (Eastleigh, UK) is celebrating its 50th anniversary this year, marking half a century of commitment to supporting clinicians, scientists, and patients across the globe.

Roche has unveiled its proprietary, sequencing by expansion (SBX) technology, establishing a new category of next-generation sequencing. SBX chemistry, combined with an innovative sensor module, offers ultra-rapid, high-throughput sequencing that is both flexible and scalable for a broad range of applications.

New research led by scientists at California’s La Jolla Institute for Immunology (LJI) reveals the workings of a human antibody called mAb 3A6, which may prove to be an important component for Ebola virus therapeutics.